We are live on ! Find out more
HARP

Harpoon Therapeutics, Inc. Common Stock

Delisted

HARP was delisted on the 8th of March, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
MB
1
MPM BioImpact
Massachusetts
$44.3M -$13.4M -70,171 -18%
MAM
2
MPM Asset Management
Massachusetts
$43.4M -$2.06M -10,804 -3%
O
3
OrbiMed
New York
$36.2M +$6.21M +32,561 +14%
BlackRock
4
BlackRock
New York
$23.8M +$873K +4,575 +3%
APM
5
Avidity Partners Management
Texas
$20.8M +$1.76M +9,200 +7%
State Street
6
State Street
Massachusetts
$18.4M +$21.4M +112,370 +549%
Vanguard Group
7
Vanguard Group
Pennsylvania
$17.4M +$1.29M +6,772 +6%
Franklin Resources
8
Franklin Resources
California
$15.8M +$1.2M +6,297 +6%
AG
9
Artal Group
Luxembourg
$13.9M
LGM
10
Logos Global Management
California
$11.1M +$9.54M +50,000 +167%
ACM
11
Aquilo Capital Management
California
$9.88M -$16.1M -84,153 -54%
LCM
12
Laurion Capital Management
New York
$8.75M +$3.76M +19,727 +46%
MS
13
Maven Securities
Jersey
$8.46M +$9.32M +48,861 +376%
SAM
14
Sectoral Asset Management
Quebec, Canada
$8.05M -$959K -5,029 -8%
CAM
15
Cormorant Asset Management
Massachusetts
$7.5M -$572K -3,000 -5%
VA
16
VR Adviser
New York
$7.1M +$9.77M +51,201 New
CS
17
Candriam SCA
Luxembourg
$6.79M +$9.34M +48,948 +1,631,600%
NCM
18
Nantahala Capital Management
Connecticut
$6.15M -$182K -956 -2%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$4.88M +$1.08M +5,669 +19%
NLVP
20
New Leaf Venture Partners
New York
$3.36M
JP Morgan Chase
21
JP Morgan Chase
New York
$3.17M -$225K -1,177 -5%
MWNA
22
Marshall Wace North America
New York
$3.16M +$105K +548 +2%
Goldman Sachs
23
Goldman Sachs
New York
$3.09M +$3.41M +17,884 +405%
Morgan Stanley
24
Morgan Stanley
New York
$2.96M +$4.03M +21,134 +12,808%
Northern Trust
25
Northern Trust
Illinois
$2.9M +$585K +3,066 +17%